Sage Therapeutics, Inc. ( SAGE) - Key Metrics
Stock symbol SAGE is outdated, potentially delisted? Maybe it is available on other exchange?
SAGE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.51 | -$0.79 | -$0.94 | -$0.94 |
| 2025Q1 | $0.23 | -$1.01 | -$1.32 | -$1.32 |
| 2024Q4 | $0.21 | -$1.58 | -$1.10 | -$1.10 |
| 2024Q3 | $0.19 | -$1.53 | -$1.35 | -$1.35 |
| 2024Q2 | $0.14 | -$1.70 | -$1.33 | -$1.33 |
SAGE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -2.88 |
| 2025Q1 | ? | -1.98 |
| 2024Q4 | ? | -0.86 |
| 2024Q3 | ? | -1.18 |
| 2024Q2 | ? | -1.62 |
SAGE
Price: $8.68
52 week price:
Earnings Per Share: -4.89 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 427700
Ebitda: -74.2 millionMarket Capitalization: 544.9 million